Achieve life sciences announces participation at upcoming investor conferences

Seattle and vancouver, british columbia, march 06, 2024 (globe newswire) -- achieve life sciences, inc. (nasdaq: achv), a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today announced that achieve management will be participating in the following upcoming investor conferences.
ACHV Ratings Summary
ACHV Quant Ranking